Tracy Lawson is eagerly awaiting the release of her coming-of-age thriller, Counteract. It’s the story of a girl (Careen), a guy (Tommy), the terrorist attack that brings them together, and their race to expose a conspiracy that could destroy their country.
In Counteract, Careen survived a terrorist’s bomb when she was a kid, and now the threat of a chemical weapons attack is literally hanging over her head. She takes the antidote offered by the government, but is unprepared for the side effects, which cause her to hallucinate, affect her memory, and derail her from her university studies. Her erratic behavior attracts the attention of a young law enforcement officer, who mistakenly pegs her as a dissident and pursues her, hoping she’ll make contact with a known resistance group. Careen doesn’t realize the antidote is causing her confusion… until she runs out on the day of the anticipated attack.
Tommy, recuperating from injuries sustained in a recent auto accident, is unaware that there’s a link between that accident, which killed his parents, and the chemical weapons attack that threatens him now. The antidote plagues him with hallucinations of tragedy and loss, and sends him spiraling into despair. When he discovers that working out before he takes his dose helps him feel more like himself, he defies the rules to regain his strength and his sanity. On the day of the attack, he meets Careen, who just might be the girl of his dreams, and tries to save her by sharing his last dose with her, even though doing so could potentially hasten his own death.
What Careen and Tommy learn about the true nature of the terrorist threat spurs them to take action, and their decisions lead them to run afoul of local law enforcement, team up with that underground resistance group, and ultimately take their quest for the truth to the highest reaches of the United States government.
Resist, the second volume in the trilogy, is nearing completion, and Tracy is now commencing work on the as-yet-unnamed final installment in Tommy and Careen’s saga.